Join to View Full Profile
2450 S TELSHOR BLVDLas Cruces, NM 88011
Are you Dr. Wertheim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Wertheim, MD is an oncologist in Las Cruces, New Mexico. He is currently licensed to practice medicine in New Mexico and Florida.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1980 - 1983
State University of New York Downstate Medical Center College of MedicineClass of 1980
Certifications & Licensure
NM State Medical License 2023 - 2027
FL State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsBintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial.Alexander Spira, Michael S Wertheim, Edward J Kim, Benjamin Tan, Heinz-Josef Lenz
The Oncologist. 2023-02-08 - 78 citationsParsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.Andres Forero-Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub, Michael S. Wertheim, William Jeffery Edenfield
Blood. 2019-04-18 - 375 citationsRandomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung CancerDavid R. Spigel, Thomas Ervin, Rodryg Ramlau, Davey B. Daniel, J. Goldschmidt
Journal of Clinical Oncology. 2013-11-10
